Filing Flows › Rhythm Pharmaceuticals (RYTM) › How it makes money
How Rhythm Pharmaceuticals (RYTM) makes money
Rhythm Pharmaceuticals (RYTM) made $92.1M of revenue in the third quarter 2026 (Q3 2026), +80% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $92.1M | 100.0% |
| Income tax | $610K | 0.7% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $92.1M | +80% |
| Q2 2026 | $71.3M | +47% |
| Q1 2026 | $60.1M | +84% |
| Q4 2025 | $57.3M | +37% |
| Q3 2025 | $51.3M | +54% |
| Q2 2025 | $48.5M | +67% |
| Q1 2025 | $32.7M | +26% |
From Rhythm Pharmaceuticals' 10-Q filed Nov 3, 2026 (on EDGAR).
Questions
How does Rhythm Pharmaceuticals make money?
Rhythm Pharmaceuticals (RYTM) made $92.1M of revenue in the third quarter 2026 (Q3 2026), +80% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.